BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10680908)

  • 21. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification and Pathology of Lung Cancer.
    Zheng M
    Surg Oncol Clin N Am; 2016 Jul; 25(3):447-68. PubMed ID: 27261908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
    Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
    [No Abstract]   [Full Text] [Related]  

  • 24. [WHO 1999 classification of lung cancers: a guided tour].
    Brambilla E
    Ann Pathol; 1999; 19(5 Suppl):S47-9. PubMed ID: 10599454
    [No Abstract]   [Full Text] [Related]  

  • 25. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
    Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
    J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
    Findeis-Hosey JJ; Xu H
    Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Calcium-binding protein secretagogin is a novel neuroendocrine marker].
    Wang WJ; Zhang F; Xu GX; Chen C
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):627-8. PubMed ID: 21092592
    [No Abstract]   [Full Text] [Related]  

  • 29. [Morphological diagnosis and classification of lung tumors].
    Kraft R
    Ther Umsch; 1994 Apr; 51(4):231-7. PubMed ID: 8191386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.
    Cameselle-Teijeiro JM; Mato Mato JA; Fernández Calvo O; García Mata J
    Mol Diagn Ther; 2018 Apr; 22(2):169-177. PubMed ID: 29427124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
    Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
    Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary Neuroendocrine Tumors: Part I. Spectrum and Characteristics of Tumors.
    Dincer HE; Podgaetz E; Andrade RS
    J Bronchology Interv Pulmonol; 2015 Jul; 22(3):267-73. PubMed ID: 26165900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuroendocrine system and its tumors: an overview.
    DeLellis RA
    Am J Clin Pathol; 2001 Jun; 115 Suppl():S5-16. PubMed ID: 11993690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression of TTF-1 and neuroendocrine markers in the human fetal lung and pulmonary neuroendocrine tumors.
    Miskovic J; Brekalo Z; Vukojevic K; Miskovic HR; Kraljevic D; Todorovic J; Soljic V
    Acta Histochem; 2015; 117(4-5):451-9. PubMed ID: 25722034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine neoplasia. Current concepts.
    Wick MR
    Am J Clin Pathol; 2000 Mar; 113(3):331-5. PubMed ID: 10705811
    [No Abstract]   [Full Text] [Related]  

  • 37. [Grading of neuroendocrine tumors].
    Saeger W; Schnabel PA; Komminoth P
    Pathologe; 2016 Jul; 37(4):304-13. PubMed ID: 27379621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polysialylated neural cell adhesion molecule as a marker for differential diagnosis in pediatric tumors.
    Glüer S; Schelp C; Gerardy-Schahn R; von Schweinitz D
    J Pediatr Surg; 1998 Oct; 33(10):1516-20. PubMed ID: 9802804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreas neuroendocrine tumors - not so rare or benign.
    Pereira Pérez F
    Rev Esp Enferm Dig; 2016 Nov; 108(11):687-688. PubMed ID: 27756141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-L1 expression in neuroendocrine tumors of the lung.
    Tsuruoka K; Horinouchi H; Goto Y; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Asakura K; Nakagawa K; Sakurai H; Watanabe SI; Tsuta K; Ohe Y
    Lung Cancer; 2017 Jun; 108():115-120. PubMed ID: 28625622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.